Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine

Archives of Histology and Cytology

Volumn 67, Issue 3, 2004, Pages 241-251

  Kadota, Tomoko ^a,c   Kadota, Ken ^b  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chiba City Inst Hlth Environ S   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; METHAMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PREFRONTAL CORTEX; RAT; SENSITIZATION; STEREOTYPY;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; DOPAMINE AGENTS; DOPAMINE BETA-HYDROXYLASE; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

EID: 10044277764     PISSN: 09149465     EISSN: None     Source Type: Journal    
DOI: 10.1679/aohc.67.241     Document Type: Article

References (48)

1. Angrist B: Amphetamine psychosis: clinical variations of the syndrome. In: Amphetamine and its analogs (Cho AK, Segal PS, ed). Academic Press, San Diego-New York-Boston-London-Sydney-Tokyo-Toronto, 1994 (p. 387-414).
2. Asanuma M, Miyazaki I, Higashi Y, Cadet JL, Ogawa N: Methamphetamine- induced increase in striatal p 53 DNA-binding activity is attenuated in Cu, Zn-dismutase transgenic mice. Neuroscience Lett 325: 191-194 (2002).
3. Azuma M, Chiba T: Afferent connections of infralimbic cortex of the rat. Acta Anat Nippon 71: 523-540 (1996).
4. Banks KE, Gratton A: Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function. Europ J Pharmacol 282: 157-167 (1995).
5. Bjõrklund A, Lindvall O: Dopamine-containing system in the CNS. In: Handbook of chemical neuroanatomy (Bjõrklund A, Hõkfelt T, ed.), Vol. 2. Classical Transmitters in the CNS, Part 1. Elsevier, Amsterdam-New York-Oxford, 1984 (p. 55-122)
6. Bubser M, Schmidt WJ: 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alteration tasks, but does no affect uninterrupted tasks in the radial maze. Behav Brain Res 37: 157-168 (1990).
7. Deng X, Cadet JL: Methamphetamine-induced apoptosis is attenuated in the striata of copper-zink superoxide dismutase transgenic mice. Mol Brain Res 83: 121-124 (2000).
8. Deng X, Ladenheim B, Tsao Li-l, Cadet JL: Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 19: 10107-10115 (1999).
9. Deng X, Wang Y, Chou J, Cadet JL: Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Mol Brain Res 93: 64-69 (2001).
10. Friedman SD, Castañeda E, Hodge GK: Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 61: 35-44 (1998).
11. Gao H-M, Liu B, Zhang W, Hon J-S: Novel anti-inflammatory therapy for Parkinson's disease. TIPS 24: 395-401 (2003).
12. Gibb JW, Hanson GR, Johnson M: Neurochemical mechanisms of toxicity. In: Amphetamine and its analogs (Cho AK, Segal PS, ed), Academic Press, San Diego-New York-Boston-London-Sydney-Tokyo-Toronto, 1994 (p. 269-295)
13. Hoffman BB, Lefkowitz RJ: Amphetamine. In: Goodman & Gilman's The pharmacological basis of therapeutics (Hardman JG, Limbird LD, ed), 9th ed. McGraw-Hill, New York and the others, 1996 (p. 219-220)
14. Ishikawa A, Nakamura S: Convergence and interaction of hippocampal and amygdalar projections within the prefrontal cortex in the rat. J Neurosci 23: 9987-9995 (2003).
15. Itzhak Y, Gandia C, Huang PL, Ali SF: Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther 284: 1040-1047 (1998).
16. Kalivas PW, Stewart J: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev 16: 223-244 (1991).
17. Karler R, Bedingfield JB, Thai DK, Calder LD: The role of frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res 757: 228-235 (1997).
18. Karoum F, Chrapusta SJ, Egan MF, Wyatt RJ: Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmento-graphic study. J Neurochem 61: 1369-1375 (1993).
19. Kita T, Matsunari Y, Saraya T, Shimada K, O'Hara K, Kubo K, Wagner GC, Nakashima T: Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice. Int J Dev Neurosci 18: 521-530 (2000a).
20. Kita T, Matsunari Y, Saraya T, Shimada K, O'Hara K, Kubo K, Wagner GC, Nakashima T: Evaluation of the effects of α-phenyl-N-tert-butyl-nitrone pretreatment on the neurobehavioral effects of methamphetamine. Life Sci 67: 1559-1571 (2000b).
21. Kita T, Wagner GC, Nakashima T: Current research on methamphetamine- induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci 92: 178-195 (2003).
22. Kolb B: Functions of the frontal cortex of the rat. Brain Res Rev 8: 65-98 (1984).
23. Kolb B: Association cortex. In: The cerebral cortex of the rat. (Kolb B, Tees RC ed.). MIT, Cambridge, 1990 (p. 431-471)
24. Kratofil PH, Baberg HT, Dimsdale JE: Self-mutilation and severe self injurious behavior associated with amphetamine psychosis. Gen Hosp Psychiat 18: 117-120 (1996).
25. Lillrank SM, Dja SS, Saransaari P: Animal models of amphetamine psychosis: neurotransmitter release from rat brain slices. Int J Neurosci 60: 1-15 (1991).
26. Machiyama Y: Chronic methamphtamine intoxication model of schizophrenia in animals. Schizophr Bull 18: 107-113 (1992).
27. Mueller K, Saboda S, Palmour R, Nyhan WL: Self-injurious behavior produced in rats by daily caffeine and continuous amphetamine. Pharmacol Biochem Behav 17: 613-617 (1982).
28. Paulson PE, Robinson TE: Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology 104: 140-141 (1991).
29. Ricaurte GA, Schuster CR, Seiden LS: Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193: 153-163 (1980).
30. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY: Dopamine nerve terminal degeneration produced by high dose of methylamphetamine in the rat brain. Brain Res 235: 93-103 (1982).
31. Ridley RM, Baker HF, Frith CD, Dowdy J, Crow TJ: Stereotyped responding on a two choice guessing task by marmosets and humans treated with amphetamine. Psychopharmacology 95: 560-564 (1988).
32. Robinson TE, Becker JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of amphetamine psychosis. Brain Res Rev 11: 157-198 (1986).
33. Robinson TE, Berridge KC: The neural basis of drug craving: an insentive-sensitization theory of addiction. Brain Res Rev 18: 247-291 (1993).
34. Robinson TE, Kolb B: Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491-8497 (1997).
35. Rosenkilde CE: Functions of the prefrontal cortex: behavioral investigations using ablation and electrophysiological techniques in rats, cats, dogs and monkeys. Acta Physiol Scand Suppl 514: 4-58 (1983).
36. Sato M: A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann NY Acad Sci 654: 160-170 (1992).
37. Segal DS, Kuczenski R: Behavioral pharmacology of amphetamine. In: Amphetamine and its analogs (Cho AK, Segal PS, ed). Academic Press, San Diego-New York-Boston-London-Sydney-Tokyo-Toronto, 1994 (p. 115-150).
38. Seiden LS, Vosmer G: Formation of 6-hydroxy-dopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmarol Biochem Behav 21: 29-31 (1984).
39. Steketee JD: Intra-A10 injection of H7 blocks the development of sensitization to cocaine. Neuroreport 6: 69-72 (1994).
40. Steketee JD: Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Rev 41: 203-228 (2003).
41. Takagishi M, Chiba T: Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res 566: 26-39 (1991).
42. Tolliver BK, Ho LB, Reid MS, Berger SP: Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants. J Pharmacol Exp Ther 278: 411-420 (1996).
43. Trulson ME, Cannon MS, Faegg TS, Raese JD: Tyrosine hydroxylase immunohistochemistry and quantitative light microscopic studies of mesolimbic dopamine system in rat brain: Effects of chronic methamphetamine administration. Brain Res Bull 18: 269-277 (1987).
44. Utena H: On relapse-liability: Schizophrenia, amphetamine psychosis and animal model. In: Biological mechanisms of schizophrenia and schizophrenia-like psychoses (Mitsuda H, Fukuda T ed.). Igaku Shoin, Tokyo, 1974 (p. 285-287)
45. Valadez A, Schenk S: Persistence of the ability of amphetamine pre-exposure to facilitate acquisition of cocaine self-administration. Pharmacol Biochem Behav 47: 203-205 (1994).
46. Wallace TL, Gudelsky GA, Vorhees CV: Neurotoxic regiment of methamphetamine produces evidence of behavioral sensitization in the rat. Synapse 39: 1-7 (2001).
47. Wolf ME, Dahlin SL, Hu XT, Xue CJ, White K: Effects of lesions of prefrontal cortex, amygdala or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience 69: 417-439 (1995).
48. Zilles K: The cortex of the rat. A stereotaxic atlas with 130 figures. Springer-Verlag-Berlin-Heidelberg-New York-Tokyo, 1985.